Varenicline Kit
Product Images NDC 49884-944

8 FDA label images from Par Health Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Varenicline (NDC 49884-944). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem-stru (Varenicline 1)

Chem-stru (Varenicline 1)
Chemical structure of varenicline tartrate, the active ingredient in the drug Varenicline. The image shows molecular configurations including the varenicline moiety and the tartrate and sugar components associated with it.*
FDA Label Image

Figure-1 (Varenicline 2)

Figure-1 (Varenicline 2)
A bar chart comparing percentages for different treatment groups across four studies labeled STUDY 2, STUDY 3, STUDY 4, and STUDY 5. Each study shows data for varenicline in various doses or schedules, bupropion SR 150 mg BID, and placebo, with bars displaying percent values on the y-axis up to 60%. Error bars indicate variability for each group.*
FDA Label Image

Figure-2 (Varenicline 3)

Figure-2 (Varenicline 3)
This image is a grouped bar chart displaying results from four separate studies comparing Varenicline (0.5 mg and 1.0 mg doses), Varenicline flexible dosing, Bupropion SR 150 mg BID, and placebo. Each study set shows percentage outcomes with error bars indicating variability. The x-axis lists different drug groups per study, and the y-axis shows percentages ranging from 0% to 35%.*
FDA Label Image

Figure-3 (Varenicline 4)

Figure-3 (Varenicline 4)
Line graph comparing the percentage of continuous abstinent subjects over time during nontreatment follow-up weeks between Varenicline 1.0 mg BID and placebo groups. The x-axis shows weeks of follow-up; the y-axis represents the percentage continuously abstinent, showing a decline over time for both groups with higher percentages for Varenicline.*
FDA Label Image

Label_05_mg-56_tab-par_health.jpg (Varenicline 5)

Label_05_mg-56_tab-par_health.jpg (Varenicline 5)
Label for Varenicline Tablets 0.5 mg film-coated oral tablets by Par Health USA, LLC. The carton contains 56 tablets. The label includes dosage strength, pharmacist instructions, storage conditions, and a barcode.*
FDA Label Image

Label_1_mg-56_tab-par_health.jpg (Varenicline 6)

Label_1_mg-56_tab-par_health.jpg (Varenicline 6)
Label for Varenicline Tablets 1 mg film-coated tablets by Par Health USA, LLC, containing 56 tablets. The label states each tablet contains 1.71 mg varenicline tartrate equivalent to 1 mg varenicline base. Storage instructions and pharmacist dispensing guidance are also shown alongside the product name, dosage, and manufacturer details.*
FDA Label Image

Starter_kit_carton_-_par_health.jpg (Varenicline 7)

Starter_kit_carton_-_par_health.jpg (Varenicline 7)
Varenicline Tablets Starting Month Box by Par Health USA, LLC. This blister card package contains a 4-week supply with 11 tablets of 0.5 mg and 42 tablets of 1 mg varenicline tartrate in film-coated oral tablet form. The label includes dosage instructions, storage conditions, and a barcode.*
FDA Label Image

Green_blister_mentor_media_-_par_health.jpg (Varenicline 8)

Green_blister_mentor_media_-_par_health.jpg (Varenicline 8)
Varenicline Tablets Starting Pack carton from Par Health USA, LLC features a blister card design for oral film-coated tablets. The pack includes a Starting Week with 0.5 mg tablets (11 count) in green panels and Continuing Weeks with 1 mg tablets (42 count) in blue panels. Text details dosage instructions and storage information. The label includes NDC 49884-944-99 and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.